Dagmar Pich

2.9k total citations
29 papers, 2.3k citations indexed

About

Dagmar Pich is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Dagmar Pich has authored 29 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Dagmar Pich's work include Viral-associated cancers and disorders (21 papers), Cytomegalovirus and herpesvirus research (14 papers) and Parvovirus B19 Infection Studies (6 papers). Dagmar Pich is often cited by papers focused on Viral-associated cancers and disorders (21 papers), Cytomegalovirus and herpesvirus research (14 papers) and Parvovirus B19 Infection Studies (6 papers). Dagmar Pich collaborates with scholars based in Germany, United States and Switzerland. Dagmar Pich's co-authors include Wolfgang Hammerschmidt, Reinhard Zeidler, Henri‐Jacques Delecluse, Aloys Schepers, Moritz Haneklaus, A. Rainey, Mariola Kurowska‐Stolarska, Seth L. Masters, Luke O'neill and Iain B. McInnes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The EMBO Journal.

In The Last Decade

Dagmar Pich

28 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dagmar Pich Germany 21 1.5k 935 679 563 468 29 2.3k
Claire Shannon‐Lowe United Kingdom 27 1.7k 1.1× 696 0.7× 348 0.5× 830 1.5× 791 1.7× 36 2.3k
Dai Iwakiri Japan 19 955 0.6× 454 0.5× 578 0.9× 698 1.2× 309 0.7× 26 1.8k
Seiji Maruo Japan 26 1.2k 0.8× 471 0.5× 535 0.8× 1.1k 1.9× 491 1.0× 34 2.1k
Chris Dawson United Kingdom 14 891 0.6× 405 0.4× 579 0.9× 665 1.2× 264 0.6× 16 1.8k
Gerhard Laux Germany 27 1.8k 1.2× 514 0.5× 387 0.6× 626 1.1× 974 2.1× 34 2.3k
Debbie Croom-Carter United Kingdom 24 2.5k 1.6× 674 0.7× 412 0.6× 1.1k 2.0× 1.4k 3.1× 26 3.2k
Jerome E. Tanner Canada 19 944 0.6× 530 0.6× 262 0.4× 581 1.0× 381 0.8× 34 1.7k
Michelle J. West United Kingdom 21 663 0.4× 324 0.3× 793 1.2× 419 0.7× 304 0.6× 41 1.7k
Nancy W. Abbey United States 15 1.2k 0.8× 883 0.9× 272 0.4× 392 0.7× 276 0.6× 20 1.9k
Neil Blake United Kingdom 23 1.1k 0.7× 735 0.8× 376 0.6× 1.0k 1.8× 381 0.8× 38 2.0k

Countries citing papers authored by Dagmar Pich

Since Specialization
Citations

This map shows the geographic impact of Dagmar Pich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Pich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Pich more than expected).

Fields of papers citing papers by Dagmar Pich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Pich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Pich. The network helps show where Dagmar Pich may publish in the future.

Co-authorship network of co-authors of Dagmar Pich

This figure shows the co-authorship network connecting the top 25 collaborators of Dagmar Pich. A scholar is included among the top collaborators of Dagmar Pich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagmar Pich. Dagmar Pich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pich, Dagmar, et al.. (2023). Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model. Vaccines. 11(3). 540–540. 4 indexed citations
2.
Pich, Dagmar, Verena Krähling, Stephan Becker, et al.. (2023). SARS-CoV-2 and Epstein–Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests. Biomedicines. 11(11). 2892–2892.
3.
Pich, Dagmar, Manuel Albanese, Paul R. Wratil, et al.. (2022). Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test. PNAS Nexus. 1(2). 5 indexed citations
4.
Albanese, Manuel, et al.. (2021). Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection. PLoS Pathogens. 17(4). e1009117–e1009117. 18 indexed citations
5.
Bouvet, Mickaël, Takanobu Tagawa, Manuel Albanese, et al.. (2021). Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus. mBio. 12(2). 40 indexed citations
6.
Buschle, Alexander, Paulina Mrozek-Górska, Filippo M. Cernilogar, et al.. (2021). Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation. Nucleic Acids Research. 49(6). 3217–3241. 20 indexed citations
7.
Liu, Wen‐Hsin, Paulina Mrozek-Górska, Anna-Katharina Wirth, et al.. (2020). Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL. Biomarker Research. 8(1). 46–46. 3 indexed citations
8.
Mrozek-Górska, Paulina, Alexander Buschle, Dagmar Pich, et al.. (2019). Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection. Proceedings of the National Academy of Sciences. 116(32). 16046–16055. 139 indexed citations
9.
Haneklaus, Moritz, Motti Gerlic, Mariola Kurowska‐Stolarska, et al.. (2012). Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production. The Journal of Immunology. 189(8). 3795–3799. 378 indexed citations
10.
Kalla, Markus, et al.. (2009). AP-1 homolog BZLF1 of Epstein–Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proceedings of the National Academy of Sciences. 107(2). 850–855. 130 indexed citations
11.
Pich, Dagmar, et al.. (2008). Conditional gene vectors regulated in cis. Nucleic Acids Research. 36(13). e83–e83. 7 indexed citations
12.
Thomae, Andreas W., Dagmar Pich, Jan Brocher, et al.. (2008). Interaction between HMGA1a and the origin recognition complex creates site-specific replication origins. Proceedings of the National Academy of Sciences. 105(5). 1692–1697. 84 indexed citations
13.
Zeidler, Reinhard, et al.. (2006). Genetic design of an optimized packaging cell line for gene vectors transducing human B cells. Gene Therapy. 13(10). 844–856. 15 indexed citations
14.
Mautner, Josef, Dagmar Pich, Falk Nimmerjahn, et al.. (2004). Epstein‐Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells. European Journal of Immunology. 34(9). 2500–2509. 47 indexed citations
15.
Gruffat, Henri, Julien Batisse, Dagmar Pich, et al.. (2002). Epstein-Barr Virus mRNA Export Factor EB2 Is Essential for Production of Infectious Virus. Journal of Virology. 76(19). 9635–9644. 73 indexed citations
16.
Baumann, Matthias, Olivier Gires, Walter Kölch, et al.. (2000). The PKC targeting protein RACK1 interacts with the Epstein–Barr virus activator protein BZLF1. European Journal of Biochemistry. 267(12). 3891–3901. 47 indexed citations
17.
Schepers, Aloys, Dagmar Pich, & Wolfgang Hammerschmidt. (1996). Activation oforiLyt,the Lytic Origin of DNA Replication of Epstein–Barr Virus, by BZLF1. Virology. 220(2). 367–376. 77 indexed citations
18.
Kempkes, Bettina, Dagmar Pich, Reinhard Zeidler, Bill Sugden, & Wolfgang Hammerschmidt. (1995). Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA. Journal of Virology. 69(1). 231–238. 91 indexed citations
19.
Gruffat, Henri, Oliver Renner, Dagmar Pich, & Wolfgang Hammerschmidt. (1995). Cellular proteins bind to the downstream component of the lytic origin of DNA replication of Epstein-Barr virus. Journal of Virology. 69(3). 1878–1886. 39 indexed citations
20.
Kempkes, Bettina, Dagmar Pich, Reinhard Zeidler, & Wolfgang Hammerschmidt. (1995). Immortalization of human primary B lymphocytes in vitro with DNA.. Proceedings of the National Academy of Sciences. 92(13). 5875–5879. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Shannon‐Lowe Breakdown of academic impact, for papers by Dai Iwakiri Breakdown of academic impact, for papers by Seiji Maruo Breakdown of academic impact, for papers by Chris Dawson Breakdown of academic impact, for papers by Gerhard Laux Breakdown of academic impact, for papers by Debbie Croom-Carter Breakdown of academic impact, for papers by Jerome E. Tanner Breakdown of academic impact, for papers by Michelle J. West Breakdown of academic impact, for papers by Nancy W. Abbey Breakdown of academic impact, for papers by Neil Blake
Rankless by CCL
2026